(5H-Pyrrolo[2,3-b]pyrazin-7-yl)methanol
97%
- Product Code: 37077
CAS:
20322-08-1
Molecular Weight: | 149.15 g./mol | Molecular Formula: | C₇H₇N₃O |
---|---|---|---|
EC Number: | MDL Number: | MFCD19219183 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, dry and sealed |
Product Description:
Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various biologically active molecules. It is particularly valuable in the development of kinase inhibitors, which are crucial for treating cancers and inflammatory diseases. Its structure allows for modifications that enhance drug efficacy and selectivity. Additionally, it is employed in organic synthesis to create complex heterocyclic compounds, which are often explored for their potential therapeutic applications.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | £33.18 |
+
-
|
0.250 | 10-20 days | £66.56 |
+
-
|
(5H-Pyrrolo[2,3-b]pyrazin-7-yl)methanol
Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various biologically active molecules. It is particularly valuable in the development of kinase inhibitors, which are crucial for treating cancers and inflammatory diseases. Its structure allows for modifications that enhance drug efficacy and selectivity. Additionally, it is employed in organic synthesis to create complex heterocyclic compounds, which are often explored for their potential therapeutic applications.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :